focus -WSS

focus

author：knowledge 2025-09-29 01:36:16 - browse：5236

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： U.K. decision on ALS drug has neurologists, advocates up in arms

WSS

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

First Opinion on colorectal cancer screening: letter and response

Hundreds died while taking an arthritis drug, but nobody alerted patients

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Patients, digital health players weigh in on FTC's data privacy plan

Megan Rapinoe shares emotional post following US Women's World Cup exit

hotspot

focus

explore

Cancer drug shortages should be causing more outrage

Dozens dead from Maui wildfires: What we know about the victims

Hollywood unions extend contract negotiations for actors

Covid silver lining: Unprecedented look at human immune system

Medicare proposal to cover medical devices draws a mixed reaction

BMS, looking to build heart drug business, turns to AI for diagnosis

The high cost of giving birth even with insurance

Indictment alleges Trump's ex

Medicare details structure of new drug price negotiation program

Young boy dies in trial for Pfizer Duchenne gene therapy

focus

Pancreatic cancer is often deadly, but new discoveries are raising hope

First Opinion on colorectal cancer screening: letter and response

Trial using CRISPR to edit HIV out of cells disappoints

Republican states more likely to report Covid vaccine side effects

Aspartame and sugar

Senators push IRS to launch nonprofit hospital probe

knowledge

entertainment

hotspot

leisure time